Back to Journals » Clinical Ophthalmology » Volume 4

Original Research

Is monthly retreatment with intravitreal bevacizumab (Avastin®) necessary in neovascular age-related macular degeneration?

       
Total article views   HTML views PDF downloads Totals
9,464 Dovepress* 9,464+ 2,013 11,477
Totals 9,464 2,013 11,477
*Since 8 April 2010
+Since July 2016

View citations on Google Scholar